通过使用计算流体动力学用于功能性 mitrale regurgitation 的胸前回声心脏成像来提高有效的 regurgitant 孔口面积估计的精度
Hongning Song1, Yuanting Yang1, Mingqi Li1
1Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, No.238 Jiefang Road, Wuchang District, Wuhan, 430060, China.
The international journal of cardiovascular imaging
|August 13, 2024
概括
计算流体动力学 (CFD) 通过开发近距离等速度表面积 (PISA) 方法的校正公式,改进了功能性腹反 (FMR) 的计算. 这种基于CFD的方法提高了FMR患者有效吐孔面积 (EROA) 评估的准确性.
科学领域:
- 心血管生理学心血管生理学
- 医疗成像医学成像
- 计算流体动力学的流体动力学.
背景情况:
- 靠近等速表面积 (PISA) 方法通常用于计算功能性 mitrale regurgitation (FMR) 患者的有效吐孔面积 (EROA).
- 然而,PISA方法的准确性可能会受到诸如吐孔形状和小册子绑定等因素的影响,这可能导致EROA评估中的不准确性.
研究的目的:
- 确定影响半球PISA方法在FMR中计算EROA精度的因素.
- 开发和验证基于CFD的校正公式,以改善FMR患者的EROA计算.
主要方法:
- 创建了99个计算流体动力学 (CFD) 模型,以调查反孔形状和传单连接对EROA的影响.
- 校正因数 (形状的CF,绑定的CFt) 通过将二维PISA方法与实际孔面积进行比较来得出.
- 衍生的校正公式在62名FMR患者中得到验证,使用2D跨胸腔心声学和3D跨食道心声学 (静脉合约区域-VCA作为参考).
主要成果:
- CFD模拟确定了静脉合并长度 (VCL) 和合并深度 (CD) 作为纠正EROA的关键因素.
- 开发了一种新的校正公式: 校正的EROA (CEROA) = EROA * CFs * CFt,用于CFs和CFt的特定方程.
- 在FMR患者中应用CEROA公式导致与未经校正的EROA (0.26 ± 0.32 cm2) 相比,VCA (0.01 ± 0.13 cm2) 的偏差和一致度极限显著较小.
结论:
- 基于CFD的校正公式显著提高了使用半球PISA方法在FMR中的EROA计算的准确性.
- 在EROA评估中,这种提高的准确性可以为FMR管理中的临床决策提供更可靠的数据.
相关概念视频
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
948
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
948
Mitral Regurgitation III: Medical Management
691
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
691
Mitral Regurgitation IV: Nursing Management
608
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
608


